logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12508376 B1

PDFFull Text
Date of Patent:
Dec. 30, 2025

Filed:

Oct. 14, 2019

Dry powder inhaler

Applicant:

Mannkind Corporation, Valencia, CA (US);

Inventors:

P. Spencer Kinsey, Sandy Hook, CT (US);

Brendan Laurenzi, Rutland, MA (US);

Chad C. Smutney, Watertown, CT (US);

Benoit Adamo, South Salem, NY (US);

Joseph Guarneri, Stamford, CT (US);

Assignee:

MannKind Corporation, Valencia, CA (US);

Attorneys:

K&L Gates LLP

Brian J. Novak

Hal Gibson

Primary Examiner:

Courtney B Fredrickson

Int. Cl.
CPC ...
A61M 15/00 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 31/00 (2006.01); A61K 31/495 (2006.01); A61K 31/661 (2006.01); A61K 31/137 (2006.01); A61K 31/473 (2006.01); A61K 31/5575 (2006.01);
U.S. Cl.
CPC ...
A61M 15/0021 (2014.02); A61K 9/0075 (2013.01); A61K 9/1617 (2013.01); A61K 31/495 (2013.01); A61K 31/658 (2023.05); A61K 31/661 (2013.01); A61M 15/0025 (2014.02); A61M 15/0028 (2013.01); A61M 15/0045 (2013.01); A61M 15/0091 (2013.01); A61K 31/137 (2013.01); A61K 31/473 (2013.01); A61K 31/5575 (2013.01); A61M 2202/064 (2013.01); A61M 2205/10 (2013.01); A61M 2205/121 (2013.01); A61M 2205/128 (2013.01); A61M 2205/583 (2013.01); A61M 2206/14 (2013.01); A61M 2207/00 (2013.01);
Abstract

A dry powder inhaler including replaceable cartridges containing a dry powder for local or systemic delivery through the pulmonary tract and lungs is disclosed. The inhalers are used with inhalable dry powders, including medicament formulations comprising active agents for local or systemic delivery and for the treatment of diseases such as, pulmonary hypertension, cardiovascular disease, anaphylaxis, diabetes, obesity, cancer, and other diseases, or symptoms associated with these and other diseases, such as nausea, vomiting, pain and inflammation.

Find Patent Forward Citations

Loading…